WOLA: Advocacy for Human Rights in the Americas
Event

Chemical Reactions: U.S.-Mexico Drug Control in the Age of Fentanyl

9:30-10:45 A.M. Wednesday, 28 February 2024
1666 Connecticut Ave NW, Suite 400 Washington, D.C.  20009

Spencer Platt/Getty Images

The Washington Office on Latin America (WOLA) cordially invites you to a hybrid event:

Chemical Reactions:
U.S.-Mexico Drug Control in the Age of Fentanyl

A decade after its arrival in U.S. street markets, illegally manufactured fentanyl continues to transform the illegal drug trade in both the United States and Mexico. Fentanyl and other synthetic opioids are driving record numbers of U.S. overdose deaths. For Mexican drug trafficking organizations, fentanyl combines cheap production, high potency and ease of smuggling to generate enormous profits. National elections will take place this year in both Mexico and the United States. What are the narratives and policy proposals in play on each side of the border? How should Mexican and U.S. leaders define their countries’ interests and priorities regarding fentanyl? What are the prospects for curbing fentanyl’s devastating impacts without deepening the grave harms already being caused by the decades-long “War on Drugs”?

With:

Stephanie Brewer
Director for Mexico
WOLA

Cecilia Farfán Méndez
Head of Research, Center for U.S.-Mexican Studies
School of Global Policy and Strategy
University of California-San Diego

Peter Reuter
Distinguished University Professor
School of Public Policy and Department of Criminology and Criminal Justice
University of Maryland

and

Lisa Sánchez
Executive Director
México Unido Contra la Delincuencia (MUCD)

Moderated by:

John Walsh
Director for Drug Policy and the Andes
WOLA

DATE:  Wednesday, February 28, 2024

TIME:  9:30 am-10:45 am EST


LOCATION:

Washington Office on Latin America (WOLA)

1666 Connecticut Ave NW, Suite 400

Washington, D.C.  20009


To confirm your attendance in person, please RSVP

To view this event live, please click here

 

 

Love our content? Unlock even more!

Sign up with your email to receive exclusive reports and expert research directly to your inbox every week.

 

(Your privacy is important to us; your information will be kept confidential and secure.)